Atria Investments Inc Increases Holdings in Bristol-Myers Squibb (NYSE:BMY)
Atria Investments Inc increased its position in Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 160,279 shares of the biopharmaceutical company’s stock after acquiring an additional 7,402 shares during the period. Atria Investments Inc’s holdings […]